Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding

Scientific Reports

Volumn 5, Issue , 2015, Pages

  He, Linling ^a   Cheng, Yushao ^a   Kong, Leopold ^a,b   Azadnia, Parisa ^a   Giang, Erick ^a   Kim, Justin ^a   Wood, Malcolm R ^a   Wilson, Ian A ^a,b   Law, Mansun ^a   Zhu, Jiang ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Department of Integrative Structural and Computational Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E1 PROTEIN, HEPATITIS C VIRUS; EPITOPE; HEPATITIS VACCINE; NEUTRALIZING ANTIBODY; PROTEIN BINDING; RECOMBINANT PROTEIN; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; BIOSYNTHESIS; CHEMISTRY; DRUG DESIGN; EPITOPE MAPPING; GENE EXPRESSION; GENETICS; HEK293 CELL LINE; HEPACIVIRUS; HEPATITIS C; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR DYNAMICS; MOLECULAR GENETICS; VIROLOGY;

AMINO ACID SEQUENCE; ANTIBODIES, NEUTRALIZING; ANTIGENS, VIRAL; DRUG DESIGN; EPITOPE MAPPING; EPITOPES; GENE EXPRESSION; HEK293 CELLS; HEPACIVIRUS; HEPATITIS C; HUMANS; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECOMBINANT PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL HEPATITIS VACCINES;

EID: 84938769263     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12501     Document Type: Article

References (91)

1. Lavanchy, D. The global burden of hepatitis C. Liver Int. 29, 74-81, doi: 10.1111/j.1478-3231.2008.01934.x (2009
2. Ly, K. N., et al. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann. Intern. Med. 156, 271-278, doi: 10.7326/0003-4819-156-4-201202210-00004 (2012
3. Shepard, C. W., Finelli, L. & Alter, M. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5, 558-567, doi: 10.1016/s1473-3099(05)70216-4 (2005
4. Messina, J. P., et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61, 77-87, doi: 10.1002/hep.27259 (2015
5. deLemos, A. S. & Chung, R. T. Hepatitis C treatment: an incipient therapeutic revolution. Trends Mol. Med. 20, 315-321, doi: 10.1016/j.molmed.2014.02.002 (2014
6. Liang, T. J. Current progress in development of hepatitis C virus vaccines. Nat. Med. 19, 869-878, doi: 10.1038/nm.3183 (2013
7. Houghton, M. & Abrignani, S. Prospects for a vaccine against the hepatitis C virus. Nature 436, 961-966, doi: 10.1038/nature04081 (2005
8. Feinstone, S. M., Hu, D. J. & Major, M. E. Prospects for prophylactic and therapeutic vaccines against hepatitis C virus. Clin. Infect. Dis. 55, S25-S32, doi: 10.1093/cid/cis362 (2012
9. Bowen, D. G. & Walker, C. M. Mutational escape from CD8(+ ) T cell immunity: HCV evolution, from chimpanzees to man. J. Exp. Med. 201, 1709-1714, doi: 10.1084/jem.20050808 (2005
10. Simmonds, P. Genetic diversity and evolution of hepatitis C virus-15 years on. J. Gen. Virol. 85, 3173-3188, doi: 10.1099/vir.0.80401-0 (2004
11. Pileri, P., et al. Binding of hepatitis C virus to CD81. Science 282, 938-941, doi: 10.1126/science.282.5390.938 (1998
12. Scarselli, E., et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21, 5017-5025, doi: 10.1093/emboj/cdf529 (2002
13. Khan, A. G., et al. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2. Nature 509, 381-384, doi: 10.1038/nature13117 (2014
14. Krey, T., et al. The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS Pathog. 6, e1000762, doi: 10.1371/journal.ppat.1000762 (2010
15. Lavillette, D., et al. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J. Virol. 81, 8752-8765, doi: 10.1128/jvi.02642-06 (2007
16. Zeisel, M. B., Felmlee, D. J. & Baumert, T. F. Hepatitis C virus entry. Curr. Top. Microbiol. Immunol. 369, 87-112, doi: 10.1007/978-3-642-27340-7-4 (2013
17. Weiner, A. J., et al. Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity. J. Virol. 75, 7142-7148, doi: 10.1128/jvi.75.15.7142-7148.2001 (2001
18. Farci, P., et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc. Natl. Acad. Sci. USA 93, 15394-15399, doi: 10.1073/pnas.93.26.15394 (1996
19. Kato, N., et al. Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus. Biochem. Biophys. Res. Commun. 189, 119-127, doi: 10.1016/0006-291x(92)91533-v (1992
20. Shimizu, Y. K., et al A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 223, 409-412, doi: 10.1006/viro.1996.0497 (1996
21. Weiner, A. J., et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180, 842-848, doi: 10.1016/0042-6822(91)90104-j (1991
22. Farci, P., et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288, 339-344, doi: 10.1126/science.288.5464.339 (2000
23. Broering, T. J., et al. Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 evelope glycoprotein of hepatitis C virus. J. Virol. 83, 12473-12482, doi: 10.1128/jvi.01138-09 (2009
24. Keck, Z.-y., et al. Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate. PLoS Pathog. 8, e1002653, doi: 10.1371/journal.ppat.1002653 (2012
25. Law, M., et al. Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat. Med. 14, 25-27, doi: 10.1038/nm1698 (2008
26. Owsianka, A., et al. Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. J. Virol. 79, 11095-11104, doi: 10.1128/jvi.79.17.11095-11104.2005 (2005
27. Johansson, D. X., et al. Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus. Proc. Natl. Acad. Sci. USA 104, 16269-16274, doi: 10.1073/pnas.0705522104 (2007
28. Meunier, J.-C., et al. Isolation and characterization of broadly neutralizing human monoclonal antibodies to the E1 glycoprotein of hepatitis C virus. J. Virol. 82, 966-973, doi: 10.1128/jvi.01872-07 (2008
29. Kong, L., Kadam, R. U., Giang, E., Ruwona, T. B., Nieusma, T., Culhane, J. C., Stanfield, R. L., Dawson, P. E., Wilson, I. A., Law, M. Structure of hepatitis C virus envelope glycoprotein E1 antigenic site 314-324 in complex with antibody IGH526. J. Mol. Biol. [Epub ahead of print] doi: 10.1016.j.jmb.2015.06.012 (2015
30. Kong, L., et al. Structure of hepatitis C virus envelope glycoprotein E2 antigenic site 412 to 423 in complex with antibody AP33. J. Virol. 86, 13085-13088, doi: 10.1128/jvi.01939-12 (2012
31. Kong, L., et al. Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1. Proc. Natl. Acad. Sci. USA 109, 9499-9504, doi: 10.1073/pnas.1202924109 (2012
32. Krey, T., et al. Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape. PLoS Pathog. 9, e1003364, doi: 10.1371/journal.ppat.1003364 (2013
33. Potter, J. A., et al. Toward a hepatitis C virus vaccine: the structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibody. J. Virol. 86, 12923-12932, doi: 10.1128/jvi.02052-12 (2012
34. Pantua, H., et al. Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies. J. Mol. Biol. 425, 1899-1914, doi: 10.1016/j.jmb.2013.02.025 (2013
35. Kong, L., et al. Hepatitis C virus E2 envelope glycoprotein core structure. Science 342, 1090-1094, doi: 10.1126/science.1243876 (2013
36. Fauvelle, C., Felmlee, D. J. & Baumert, T. F. Unraveling hepatitis C virus structure. Cell Res. 24, 385-386, doi: 10.1038/cr.2014.31 (2014
37. Di Lorenzo, C., Angus, A. G. N. & Patel, A. H. Hepatitis C virus evasion mechanisms from neutralizing antibodies. Viruses-Basel 3, 2280-2300, doi: 10.3390/v3112280 (2011
38. Helle, F., Duverlie, G. & Dubuisson, J. The hepatitis C virus glycan shield and evasion of the humoral immune response. Viruses-Basel 3, 1909-1932, doi: 10.3390/v3101909 (2011
39. Burton, D. R. Scaffolding to build a rational vaccine design strategy. Proc. Natl. Acad. Sci. USA 107, 17859-17860, doi: 10.1073/pnas.1012923107 (2010
40. Correia, B. E., et al. Computational protein design using flexible backbone remodeling and resurfacing: case studies in structurebased antigen design. J. Mol. Biol. 405, 284-297, doi: 10.1016/j.jmb.2010.09.061 (2011
41. Ofek, G., et al. Elicitation of structure-specific antibodies by epitope scaffolds. Proc. Natl. Acad. Sci. USA 107, 17880-17887, doi: 10.1073/pnas.1004728107 (2010
42. Zhou, T., et al. Transplanting supersites of HIV-1 vulnerability. PLoS ONE 9, e99881, doi: 10.1371/journal.pone.0099881 (2014
43. McLellan, J. S., et al. Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus. J. Mol. Biol. 409, 853-866, doi: 10.1016/j.jmb.2011.04.044 (2011
44. Correia, B. E., et al. Proof of principle for epitope-focused vaccine design. Nature 507, 201-206, doi: 10.1038/nature12966 (2014
45. He, L. & Zhu, J. Computational tools for epitope vaccine design and evaluation. Curr. Opin. Virol. 11, 103-112, doi: 10.1016/j. coviro.2015.03.013 (2015
46. Correia, B. E., et al. Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope. Structure 18, 1116-1126, doi: 10.1016/j.str.2010.06.010 (2010
47. Azoitei, M. L., et al. Computational design of high-Affinity epitope scaffolds by backbone grafting of a linear epitope. J. Mol. Biol. 415, 175-192, doi: 10.1016/j.jmb.2011.10.003 (2012
48. Zhang, Y. Progress and challenges in protein structure prediction. Curr. Opin. Struct. Biol. 18, 342-348, doi: 10.1016/i. sbi.2008.02.004 (2008
49. Ortiz, A. R., Strauss, C. E. M. & Olmea, O. MAMMOTH (Matching molecular models obtained from theory): An automated method for model comparison. Protein Sci. 11, 2606-2621, doi: 10.1110/ps.0215902 (2002
50. Zhang, Y. & Skolnick, J. TM-Align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res. 33, 2302-2309, doi: 10.1093/nar/gki524 (2005
51. Yang, Y., Zhan, J., Zhao, H. & Zhou, Y A new size-independent score for pairwise protein structure alignment and its application to structure classification and nucleic-Acid binding prediction. Proteins 80, 2080-2088, doi: 10.1002/prot.24100 (2012
52. Nguyen, M. N., Tan, K. P. & Madhusudhan, M. S. CLICK-Topology-independent comparison of biomolecular 3D structures. Nucleic Acids Res. 39, W24-W28, doi: 10.1093/nar/gkr393 (2011
53. Zhu, J. H. & Weng, Z. P. FAST: A novel protein structure alignment algorithm. Proteins 58, 618-627, doi: 10.1002/prot.20331 (2005
54. Wang, G. L. & Dunbrack, R. L. PISCES: a protein sequence culling server. Bioinformatics 19, 1589-1591, doi: 10.1093/bioinformatics/btg224 (2003
55. Zhou, H. Y. & Zhou, Y. Q. Distance-scaled, finite ideal-gas reference state improves structure-derived potentials of mean force for structure selection and stability prediction. Protein Sci. 11, 2714-2726, doi: 10.1110/ps.0217002 (2002
56. Zhu, J., Fan, H., Periole, X., Honig, B. & Mark, A. E. Refining homology models by combining replica-exchange molecular dynamics and statistical potentials. Proteins 72, 1171-1188, doi: 10.1002/prot.22005 (2008
57. Ruwona, T. B., Giang, E., Nieusma, T. & Law, M. Fine mapping of murine antibody responses to immunization with a novel soluble form of hepatitis C virus envelope glycoprotein complex. J. Virol. 88, 10459-10471, doi: 10.1128/jvi.01584-14 (2014
58. Brautigam, C. A., et al. Structural insight into interactions between dihydrolipoamide dehydrogenase (E3) and E3 binding protein of human pyruvate dehydrogenase complex. Structure 14, 611-621, doi: 10.1016/j.str.2006.01.001 (2006
59. Schmeing, T. M., Huang, K. S., Kitchen, D. E., Strobel, S. A. & Steitz, T. A. Structural insights into the roles of water and the 2? hydroxyl of the P site tRNA in the peptidyl transferase reaction. Mol. Cell 20, 437-448, doi: 10.1016/j.molcel.2005.09.006 (2005
60. Bartosch, B., et al. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem. 278, 41624-41630, doi: 10.1074/jbc.M305289200 (2003
61. Safaee, N., et al. Interdomain allostery promotes assembly of the poly(A) mRNA complex with PABP and eIF4G. Mol. Cell 48, 375-386, doi: 10.1016/j.molcel.2012.09.001 (2012
62. Grgacic, E. V. L. & Anderson, D. A. Virus-like particles: Passport to immune recognition. Methods 40, 60-65, doi: 10.1016/j. ymeth.2006.07.018 (2006
63. Ludwig, C. & Wagner, R. Virus-like particles-universal molecular toolboxes. Curr. Opin. Biotechnol. 18, 537-545, doi: 10.1016/j. copbio.2007.10.013 (2007
64. Jennings, G. T. & Bachmann, M. F. Coming of age of virus-like particle vaccines. Biol. Chem. 389, 521-536, doi: 10.1515/bc.2008.064 (2008
65. Rodriguez-Limas, W. A., Sekar, K. & Tyo, K. E. J. Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development. Curr. Opin. Biotechnol. 24, 1089-1093, doi: 10.1016/j.copbio.2013.02.008 (2013
66. Dintzis, R. Z., Vogelstein, B. & Dintzis, H. M. Specific cellular stimulation in the primary immune response: experimental test of a quantized model. Proc. Natl. Acad. Sci. USA 79, 884-888, doi: 10.1073/pnas.79.3.884 (1982
67. Jardine, J., et al. Rational HIV immunogen design to target specific germline B cell receptors. Science 340, 711-716, doi: 10.1126/science.1234150 (2013
68. Kanekiyo, M., et al. Self-Assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499, 102-106, doi: 10.1038/nature12202 (2013
69. Walker, L. M. & Burton, D. R. Rational antibody-based HIV-1 vaccine design: current approaches and future directions. Curr. Opin. Immunol. 22, 358-366 (2010
70. Craik, D. J., Cemazar, M. & Daly, N. L. The cyclotides and related macrocyclic peptides as scaffolds in drug design. Curr. Opin. Drug Discovery Dev. 9, 251-260 (2006
71. Craik, D. J., Simonsen, S. & Daly, N. L. The cyclotides: Novel macrocyclic peptides as scaffolds in drug design. Curr. Opin. Drug Discovery Dev. 5, 251-260 (2002
72. Stumpp, M. T. & Amstutz, P. DARPins: A true alternative to antibodies. Curr. Opin. Drug Discovery Dev. 10, 153-159 (2007
73. Stumpp, M. T., Binz, H. K. & Amstutz, P. DARPins: A new generation of protein therapeutics. Drug Discovery Today 13, 695-701, doi: 10.1016/j.drudis.2008.04.013 (2008
74. Fleishman, S. J., et al. Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science 332, 816-821, doi: 10.1126/science.1202617 (2011
75. Ginalski, K., Elofsson, A., Fischer, D. & Rychlewski, L. 3D-Jury: a simple approach to improve protein structure predictions. Bioinformatics 19, 1015-1018, doi: 10.1093/bioinformatics/btg124 (2003
76. Fischer, D. 3D-SHOTGUN: A novel, cooperative, fold-recognition meta-predictor. Proteins 51, 434-441, doi: 10.1002/prot.10357 (2003
77. Lua, L. H. L., et al. Bioengineering virus-like particles as vaccines. Biotechnol. Bioeng. 111, 425-440, doi: 10.1002/bit.25159 (2014
78. Zhu, J., et al. Structural model of the TRPP2/PKD1 C-Terminal coiled-coil complex produced by a combined computational and experimental approach. Proc. Natl. Acad. Sci. USA 108, 10133-10138, doi: 10.1073/pnas.1017669108 (2011
79. Soto, C. S., Fasnacht, M., Zhu, J., Forrest, L. & Honig, B. Loop modeling: Sampling, filtering, and scoring. Proteins 70, 834-843, doi: 10.1002/prot.21612 (2008
80. Zhu, J., Xie, L. & Honig, B. Structural refinement of protein segments containing secondary structure elements: Local sampling, knowledge-based potentials, and clustering. Proteins 65, 463-479, doi: 10.1002/prot.21085 (2006
81. Zhu, J., Cheng, L., Fang, Q., Zhou, Z. H. & Honig, B. Building and refining protein models within cryo-electron microscopy density maps based on homology modeling and multiscale structure refinement. J. Mol. Biol. 397, 835-851, doi: 10.1016/j. jmb.2010.01.041 (2010
82. Xiang, Z. X. & Honig, B. Extending the accuracy limits of prediction for side-chain conformations. J. Mol. Biol. 311, 421-430, doi: 10.1006/jmbi.2001.4865 (2001
83. Desmet, J., Spriet, J. & Lasters, I. Fast and Accurate Side-Chain Topology and Energy Refinement (FASTER) as a new method for protein structure optimization. Proteins 48, 31-43, doi: 10.1002/prot.10131 (2002
84. Ponder, J. W. & Richards, F. M. An efficient Newton-like method for molecular mechanics energy minimization of large molecules. J. Comput. Chem. 8, 1016-1024, doi: 10.1002/jcc.540080710 (1987
85. Jorgensen, W. L. & Tiradorives, J. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J. Am. Chem. Soc. 110, 1657-1666, doi: 10.1021/ja00214a001 (1988
86. Berendsen, H. J. C., Vanderspoel, D. & Vandrunen, R. GROMACS: A message-passing parallel molecular dynamics implementation. Comput. Phys. Commun. 91, 43-56, doi: 10.1016/0010-4655(95)00042-e (1995
87. Lindahl, E., Hess, B. & van der Spoel, D. GROMACS 3.0: a package for molecular simulation and trajectory analysis. J. Mol. Model. 7, 306-317, doi: 10.1007/s008940100045 (2001
88. Essmann, U., et al A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577-8593, doi: 10.1063/1.470117 (1995
89. Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463-1472, doi: 10.1002/(sici)1096-987x(199709)18: 12 3.0.co; 2-h (1997
90. Miyamoto, S. & Kollman, P. A. Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. J. Comput. Chem. 13, 952-962, doi: 10.1002/jcc.540130805 (1992
91. Berendsen, H. J. C., Postma, J. P. M., Vangunsteren, W. F., Dinola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684-3690, doi: 10.1063/1.448118 (1984